<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Actulligence</title>
	<atom:link href="https://www.actulligence.com/en/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.actulligence.com/en/home-2/</link>
	<description>Transformez l&#039;information en action</description>
	<lastBuildDate>Tue, 31 Mar 2026 15:01:17 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.actulligence.com/wp-content/uploads/2023/10/favicon_Actulligence-150x150.png</url>
	<title>Actulligence</title>
	<link>https://www.actulligence.com/en/home-2/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Artificial Intelligence and Competitive Intelligence</title>
		<link>https://www.actulligence.com/en/2025/01/08/artificial-intelligence-and-competitive-intelligence/</link>
					<comments>https://www.actulligence.com/en/2025/01/08/artificial-intelligence-and-competitive-intelligence/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Wed, 08 Jan 2025 11:22:01 +0000</pubDate>
				<category><![CDATA[Competitive intelligence]]></category>
		<category><![CDATA[Monitoring tools]]></category>
		<category><![CDATA[Outils du veilleur]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[artificial intelligence]]></category>
		<category><![CDATA[competitive intelligence]]></category>
		<category><![CDATA[competitive search]]></category>
		<category><![CDATA[information analysis]]></category>
		<category><![CDATA[information retrieval]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/?p=7105</guid>

					<description><![CDATA[<p>On November 14th, I had the opportunity to attend a day of conferences focused on information and artificial intelligence, organized by Archimag. During the event, I was invited to speak and share my perspective as an information professional on Artificial Intelligence, its contribution to the field of competitive intelligence, and its potential limitations. Although artificial [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2025/01/08/artificial-intelligence-and-competitive-intelligence/">Artificial Intelligence and Competitive Intelligence</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2025/01/08/artificial-intelligence-and-competitive-intelligence/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>How to use the clinicaltrials.gov website for monitoring</title>
		<link>https://www.actulligence.com/en/2024/03/12/how-to-use-the-clinicaltrials-gov-website-for-monitoring/</link>
					<comments>https://www.actulligence.com/en/2024/03/12/how-to-use-the-clinicaltrials-gov-website-for-monitoring/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Tue, 12 Mar 2024 12:45:57 +0000</pubDate>
				<category><![CDATA[Competitive intelligence]]></category>
		<category><![CDATA[Monitoring]]></category>
		<category><![CDATA[Monitoring tools]]></category>
		<category><![CDATA[Non classé]]></category>
		<category><![CDATA[Pharma]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/?p=7046</guid>

					<description><![CDATA[<p>When it comes to competitive intelligence in the pharmaceutical sector, one of the key areas to monitor is clinical trials conducted by competitors. One of the best-known and most visible websites in the world is the U.S. Food and Drug Administration’s www.clinicaltrials.gov NB: This article refers to the new version of the clinicaltrials.gov website, which [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2024/03/12/how-to-use-the-clinicaltrials-gov-website-for-monitoring/">How to use the clinicaltrials.gov website for monitoring</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2024/03/12/how-to-use-the-clinicaltrials-gov-website-for-monitoring/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>MONITORING AT SANOFI: A HEALTHY COLLABORATION</title>
		<link>https://www.actulligence.com/en/2024/03/12/monitoring-at-sanofi-a-healthy-collaboration/</link>
					<comments>https://www.actulligence.com/en/2024/03/12/monitoring-at-sanofi-a-healthy-collaboration/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Tue, 12 Mar 2024 11:19:29 +0000</pubDate>
				<category><![CDATA[Non classé]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/?p=7040</guid>

					<description><![CDATA[<p>Monitoring at Sanofi: a healthy collaboration is an article on strategic and competitive intelligence that appeared in the June partner supplement of Archimag (French title&#160;: Sanofi&#160;: Une veille bien traitée) In the thirteen years that Actulligence has existed we have published very few testimonials from clients, with good reason. Business intelligence is an area where [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2024/03/12/monitoring-at-sanofi-a-healthy-collaboration/">MONITORING AT SANOFI: A HEALTHY COLLABORATION</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2024/03/12/monitoring-at-sanofi-a-healthy-collaboration/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Social listening: avoiding the pitfalls of a hasty analysis</title>
		<link>https://www.actulligence.com/en/2019/10/08/social-listening-avoiding-the-pitfalls-of-a-hasty-analysis/</link>
					<comments>https://www.actulligence.com/en/2019/10/08/social-listening-avoiding-the-pitfalls-of-a-hasty-analysis/#respond</comments>
		
		<dc:creator><![CDATA[Julien B]]></dc:creator>
		<pubDate>Tue, 08 Oct 2019 11:05:53 +0000</pubDate>
				<category><![CDATA[Actulligence @en]]></category>
		<category><![CDATA[en]]></category>
		<category><![CDATA[Monitoring]]></category>
		<category><![CDATA[Monitoring tools]]></category>
		<category><![CDATA[Online reputation]]></category>
		<category><![CDATA[e-Reputation]]></category>
		<category><![CDATA[ereputation]]></category>
		<category><![CDATA[social listening platform]]></category>
		<category><![CDATA[social listening software]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/2019/10/08/social-listening-avoiding-the-pitfalls-of-a-hasty-analysis/</guid>

					<description><![CDATA[<p>Many are the businesses wishing to speed up their digital transformation by implementing new services for their marketing and communications teams, or by integrating new technologies as data lakes or artificial intelligence. Social listening has been part of this trend through editors promoting innovative technologies able to provide insights as fast as we heat up [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2019/10/08/social-listening-avoiding-the-pitfalls-of-a-hasty-analysis/">Social listening: avoiding the pitfalls of a hasty analysis</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2019/10/08/social-listening-avoiding-the-pitfalls-of-a-hasty-analysis/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Pharma industry, drug life cycle and social listening</title>
		<link>https://www.actulligence.com/en/2019/09/17/pharma-industry-drug-life-cycle-and-social-listening/</link>
					<comments>https://www.actulligence.com/en/2019/09/17/pharma-industry-drug-life-cycle-and-social-listening/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Tue, 17 Sep 2019 16:10:24 +0000</pubDate>
				<category><![CDATA[Actulligence @en]]></category>
		<category><![CDATA[en]]></category>
		<category><![CDATA[Monitoring]]></category>
		<category><![CDATA[Monitoring tools]]></category>
		<category><![CDATA[Online reputation]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[pharmaceutique]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/2019/09/17/industrie-pharmaceutique-cycle-de-vie-du-medicament-et-social-media/</guid>

					<description><![CDATA[<p>At Actulligence, we are deeply convinced that business intelligence should not be a burden on any organization. It should rely on the organization’s existing processes to answer operational and business needs and be integrated depending on how the user operates. The usual cliché of business intelligence is the « intelligence cycle », as defined by Henri Martre [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2019/09/17/pharma-industry-drug-life-cycle-and-social-listening/">Pharma industry, drug life cycle and social listening</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2019/09/17/pharma-industry-drug-life-cycle-and-social-listening/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>GDPR, customs barrier to access to information</title>
		<link>https://www.actulligence.com/en/2019/07/03/gdpr-customs-barrier-to-access-to-information/</link>
					<comments>https://www.actulligence.com/en/2019/07/03/gdpr-customs-barrier-to-access-to-information/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Wed, 03 Jul 2019 13:00:52 +0000</pubDate>
				<category><![CDATA[Competitive intelligence]]></category>
		<category><![CDATA[Economic warfare]]></category>
		<category><![CDATA[en]]></category>
		<category><![CDATA[Indexation]]></category>
		<category><![CDATA[Information - Data management]]></category>
		<category><![CDATA[Monitoring]]></category>
		<category><![CDATA[gprd]]></category>
		<category><![CDATA[information retrieval]]></category>
		<category><![CDATA[regulatory]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/?p=3729</guid>

					<description><![CDATA[<p>Basically, the GDPR is a law that aims to protect the internet user, and more particularly allows him to better manage his personal data, and generally any information that could be used by a website, whether the data is explicitly provided (contact form, newsletter subscription, survey, etc.) or implicitly provided (environment data such as operating [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2019/07/03/gdpr-customs-barrier-to-access-to-information/">GDPR, customs barrier to access to information</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2019/07/03/gdpr-customs-barrier-to-access-to-information/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>How to easily share a page on Facebook Workplace?</title>
		<link>https://www.actulligence.com/en/2019/07/03/how-to-easily-share-a-page-on-facebook-workplace/</link>
					<comments>https://www.actulligence.com/en/2019/07/03/how-to-easily-share-a-page-on-facebook-workplace/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Wed, 03 Jul 2019 12:24:58 +0000</pubDate>
				<category><![CDATA[en]]></category>
		<category><![CDATA[Monitoring tools]]></category>
		<category><![CDATA[Bookmarklet]]></category>
		<category><![CDATA[enterprise social network]]></category>
		<category><![CDATA[facebook workplace]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/?p=3726</guid>

					<description><![CDATA[<p>The most useful tools to the monitoring process are the information sharing and publishing tools such as Corporate Social Networks. Among these social networks, I have, for the last few months, been looking more particularly at Yammer, the essential corporate social network because it is present in numerous companies that have the full Microsoft package, [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2019/07/03/how-to-easily-share-a-page-on-facebook-workplace/">How to easily share a page on Facebook Workplace?</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2019/07/03/how-to-easily-share-a-page-on-facebook-workplace/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Competitive intelligence, monitoring and artificial intelligence</title>
		<link>https://www.actulligence.com/en/2019/07/03/competitive-intelligence-monitoring-and-artificial-intelligence/</link>
					<comments>https://www.actulligence.com/en/2019/07/03/competitive-intelligence-monitoring-and-artificial-intelligence/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Wed, 03 Jul 2019 11:12:16 +0000</pubDate>
				<category><![CDATA[Competitive intelligence]]></category>
		<category><![CDATA[en]]></category>
		<category><![CDATA[Information - Data management]]></category>
		<category><![CDATA[Monitoring tools]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[artificial intelligence]]></category>
		<category><![CDATA[competitive intelligence]]></category>
		<category><![CDATA[information analysis]]></category>
		<category><![CDATA[information retrieval]]></category>
		<category><![CDATA[text mining]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/?p=3723</guid>

					<description><![CDATA[<p>In the innovations that are considered as promised to revolutionize our World, artificial intelligence is often ranked at the top of the list. Whether it be Deloitte, Bloomberg, or many other analysis or media firms, artificial intelligence is considered as the most disruptive technology at the moment. In this way, pharmaceutical laboratories, GAFA and other [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2019/07/03/competitive-intelligence-monitoring-and-artificial-intelligence/">Competitive intelligence, monitoring and artificial intelligence</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2019/07/03/competitive-intelligence-monitoring-and-artificial-intelligence/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>World Diabetes Day and dataviz</title>
		<link>https://www.actulligence.com/en/2012/11/26/world-diabete-day-and-mapping/</link>
					<comments>https://www.actulligence.com/en/2012/11/26/world-diabete-day-and-mapping/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Mon, 26 Nov 2012 09:30:31 +0000</pubDate>
				<category><![CDATA[en]]></category>
		<category><![CDATA[Mapping @en]]></category>
		<category><![CDATA[data mapping]]></category>
		<category><![CDATA[data visualization]]></category>
		<category><![CDATA[data vizualisation]]></category>
		<category><![CDATA[dataviz @en]]></category>
		<category><![CDATA[e-pharma]]></category>
		<category><![CDATA[mapping @en]]></category>
		<category><![CDATA[pharma 2.0]]></category>
		<category><![CDATA[twitter @en]]></category>
		<category><![CDATA[wdd @en]]></category>
		<category><![CDATA[world diabete day @en]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/2012/11/26/world-diabete-day-et-cartographie-2/</guid>

					<description><![CDATA[<p>Strictly speaking, this post is not a post about competitive intelligence, its tools, etc. It&#8217;s a mapping survey carried out on World Diabetes Day which was held on 14 November. It aims to show how mapping tools can easily enable an overview of stakeholders to be drawn up for a short event, as well as [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2012/11/26/world-diabete-day-and-mapping/">World Diabetes Day and dataviz</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2012/11/26/world-diabete-day-and-mapping/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Influence, Klout and API</title>
		<link>https://www.actulligence.com/en/2012/05/01/influence-klout-and-api/</link>
					<comments>https://www.actulligence.com/en/2012/05/01/influence-klout-and-api/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Tue, 01 May 2012 16:56:05 +0000</pubDate>
				<category><![CDATA[Blog - RSS - 2.0]]></category>
		<category><![CDATA[en]]></category>
		<category><![CDATA[Online reputation]]></category>
		<category><![CDATA[api]]></category>
		<category><![CDATA[influence]]></category>
		<category><![CDATA[influencer]]></category>
		<category><![CDATA[influencers detection]]></category>
		<category><![CDATA[klout]]></category>
		<category><![CDATA[kred]]></category>
		<category><![CDATA[peerindex]]></category>
		<category><![CDATA[score]]></category>
		<category><![CDATA[scoring]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/?p=2222</guid>

					<description><![CDATA[<p>Influence is a word that keeps cropping up when online reputation and its implementation are addressed. Influence is considered first and foremost as one of the analytical keys for  its community ecosystem, clients or even detractors, but also as one of the weighting keys for its opinion leaders whether they&#8217;re pro or anti. I will [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2012/05/01/influence-klout-and-api/">Influence, Klout and API</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2012/05/01/influence-klout-and-api/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
